Physician profile
Joshua Ray Brandon
NPI 1356902951
$2,880.32
in general payments reported to CMS, 2019-2025
6 companies · $2,836 in 2025
The $2,836 reported for 2025 was more than what 96% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.13 · 2022: $20.13 · 2025: $2,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,733 · Travel and Lodging: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,732.80 |
| Travel and Lodging | $1,103.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $2,358.48 | 2025 | |
| Zynex Medical, INC. | $320.81 | 2025 | Nexwave |
| Stryker Corporation | $140.04 | 2025 | Makoplasty, Dall Miles |
| Gilead Sciences, INC. | $24.13 | 2020 | |
| Neos Therapeutics, Lp | $20.13 | 2022 | |
| Smith+Nephew, INC. | $16.73 | 2025 | Coblation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Brandon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.